Tissue Engineering
Cryopreserved vascular umbilical cord cells used to engineer viable heart valves
Published in Drug Week, August 25th, 2006
According to recently published research from Germany, "Tissue engineering of autologous heart valves with the potential to grow and to remodel represents a promising concept in pediatric cardiovascular surgery.
"Currently we are exploring the impact of cryopreserved human umbilical cord cells (CHUCCs) for the fabrication of tissue-engineered heart valves for patients diagnosed prenatally with congenital heart lesions, potentially enabling heart valve replacement in the early years of life."
"Human umbilical cord cells were isolated from vascular...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2006-08-25)
More Articles from Drug Week
- Addiction Medicine
Dopamine D3 receptor antagonist blocks cocaine reward effects - Allergy & Immunology
CC chemokine receptor antagonists selectively inhibit eosinophil influx into lungs - Cell Regulation
Helenalin plays important role in Akt signaling and Skp2 expression in 3T3-L1 preadipocytes - Cystic Fibrosis
Inspire initiates phase III trial of denufosol tetrasodium in cystic fibrosis patients - DNA Vaccine
Plasmid size up to 20 kbp does not limit lung gene transfer using DNA nanoparticles - Abdominal Infections
Study finds once-daily Avelox effective as multidose antibiotic in treating abdominal infections - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
